Cargando...
Randomized, double-blind, placebo-controlled trial of arimoclomol in rapidly progressive SOD1 ALS
OBJECTIVE: To examine the safety and tolerability as well as the preliminary efficacy of arimoclomol, a heat shock protein co-inducer that promotes nascent protein folding, in patients with rapidly progressive SOD1 amyotrophic lateral sclerosis (ALS). METHODS: This was a double-blind, placebo-contro...
Gardado en:
| Publicado en: | Neurology |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Lippincott Williams & Wilkins
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5818014/ https://ncbi.nlm.nih.gov/pubmed/29367439 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000004960 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|